FDA Inspection
Friberg Medical AssociatesFriberg Medical Associates – FDA Inspection, Jan 22, 2014
Record Details
This FDA Inspection record concerns Friberg Medical Associates, with an inspection on January 22, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Friberg Medical Associates
- Inspection Date
- January 22, 2014
- Product Type
- Biologics
View Company Profile
ID · fddd3ca6-dc09-4af8-a515-85ad1279f557
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 857490
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.85(a)Infection with communicable disease agents
- 21 CFR 1271.80(d)(1)Reactive tests--not determined ineligible
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Friberg Medical Associates
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 14, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 8, 2011 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 18, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Friberg Medical Associates
- FDA Inspection 786313 - 2012-06-14
- FDA Inspection 728882 - 2011-06-08
- FDA Inspection 662667 - 2010-05-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.